Evidence map›Paper›PMID 38344645›Full record

ArticleCureus2024

Non-arteritic Anterior Ischemic Optic Neuropathy Sequela From Potential COVID-19-Associated Coagulopathy.

Sanad Naber, Nadia Alinaghizadeh, Amy Kotecha

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Sanad NaberDepartment of Research and Scholarly Activity, Rocky Vista University College of Osteopathic Medicine, Ivins, USA.
Nadia AlinaghizadehDepartment of Research and Scholarly Activity, Rocky Vista University College of Osteopathic Medicine, Ivins, USA.
Amy KotechaOpthalmology, Capital Vision Eye and Surgical Center, Arlington, USA.
Vision Eye Institute · AURocky Vista University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case involving a post-menopausal female who experienced a sudden loss of peripheral vision in her right eye seven months after a confirmed COVID-19 infection. MRI scans of the brain and orbit excluded neuritis and multiple sclerosis, leading to the diagnosis of non-arteritic anterior ischemic optic neuropathy (NAION). It is known that the intense inflammatory condition resulting from acute respiratory distress syndrome triggered by SARS-CoV-2 infections can result in a heightened tendency for blood clot formation. Emerging research underscores the potential link between the likelihood of a thrombotic event in the eye as a consequence of COVID-19 infection and the development of NAION. The connection between NAION and COVID-19, whether it is correlative or coincidental, remains uncertain. However, this case report aims to present evidence for the plausibility of this link and offer insights into potential ophthalmologic complications caused by COVID-19.

Indexed as

covid-19hypercoagulable stateischemic optic neuropathynon-arteritic anterior ischemic optic neuropathy (naion)sudden vision loss

Identifiers

PMID38344645
PMCPMC10859062
OpenAlexW4390827049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.